DECOR Information für Projekt: CDA-CH-EMED - eMedikation (cdachemed-)

Identifikatoren

Wird zurzeit nur zu Anzeigezwecken genutzt.

IHEActCode Vocabulary 1.3.6.1.4.1.19376.1.5.3.2

Sprache Anzeigename Beschreibung
de-CH IHEActCode Vocabulary IHEActCode Vocabulary

cdachemed-valueset-1 2.16.756.5.30.1.127.77.4.11.1

Sprache Anzeigename Beschreibung
de-CH cdachemed-valueset-1 cdachemed-valueset-1

cdachemed-valueset-3 2.16.756.5.30.1.127.77.4.11.3

Sprache Anzeigename Beschreibung
de-CH cdachemed-valueset-3 cdachemed-valueset-3

cdachemed-valueset-5 2.16.756.5.30.1.127.77.4.11.5

Sprache Anzeigename Beschreibung
de-CH cdachemed-valueset-5 cdachemed-valueset-5

cdachemed-valueset-6 2.16.756.5.30.1.127.77.4.11.6

Sprache Anzeigename Beschreibung
de-CH cdachemed-valueset-6 cdachemed-valueset-6

Act Code 2.16.840.1.113883.5.4

Sprache Anzeigename Beschreibung
de-CH Act Code Act Code

TimingEvent 2.16.840.1.113883.5.139

Sprache Anzeigename Beschreibung
de-CH TimingEvent TimingEvent

Logical Observation Identifier Names and Codes 2.16.840.1.113883.6.1

Sprache Anzeigename Beschreibung
de-CH Logical Observation Identifier Names and Codes Logical Observation Identifier Names and Codes

SNOMED Clinical Terms 2.16.840.1.113883.6.96

Sprache Anzeigename Beschreibung
de-CH SNOMED Clinical Terms SNOMED Clinical Terms

Liste der Template Identifier in diesem Projekt

Id Anzeigename Name Eingangsdatum Typ
CDA SetId VersionNumber CDAsetIdversionNumber
CDA-CH Vital Signs Observation CDA-CH-VitalSignsObservation
CDA Document Language Code CDAlanguageCode
CDA-CH Vital Signs Organizer Entry CDA-CH-VitalSignsOrganizerEntry
CDA-CH Remarks Entry CDACH-RemarksEntry
Dispense Item DispenseItem
CDA Document Id CDAid
Prescription Item PrescriptionItem
CDA-CH Allergies and other Adverse Reactions Section CDA-CH-AllergiesOtherAdverseReactionsSection
Medication Treatment Plan Item MedicationTreatmentPlanItem
CDA RealmCode CDArealmCode
Pharmaceutical Advice Concern Entry Content Module PharmaceuticalAdviceConcernEntryContentModule
CDA-CH Coded Vital Signs CDA-CH-CodedVitalSigns
Pharmaceutical Advice Item Entry Content Module PharmaceuticalAdviceItemEntryContentModule
Entry Medication FulFillment Instructions EntryMedicationFulFillmentInstructions
CDA-CH Remarks Section CDA-CH-RemarksSection
Prescription Item Entry Content Module PrescriptionItemEntry
Medicine Entry Content Module MedicineEntryContentModule
CDA legalAuthenticator CDAlegalAuthenticator
<CDA-CH-CONF> CDA-CH-CONF
<CDA-CH-TPLT> CDA-CH-TPLT
<CDA-CH-TPLT> CDA-CH-TPLT-V12
<CDA-CH-RELM> CDA_CH_RELM
CDA TypeId CDAtypeId
<CDA-CH-REPL> CDA_CH_REPL
<CDA-CH-DOCL> CDA_CH_DOCL
<CDA-CH-SETV> CDA_CH_SETV
epSOS Patient Medication Instructions epsosPatientMedicationInstructions
Severity Severity
1.3.6.1.4.1.12559.11.22.1.50 Medication Treatment Plan Item MedicationTreatmentPlanItem 2016‑01‑08 11:13:04
1.3.6.1.4.1.12559.11.22.1.51 Prescription Item PrescriptionItem 2016‑01‑08 11:13:04
1.3.6.1.4.1.12559.11.22.1.52 Dispense Item DispenseItem 2016‑01‑08 11:13:04
1.3.6.1.4.1.19376.1.5.3.1.4.1 Severity Severity 2009‑12‑04
1.3.6.1.4.1.19376.1.5.3.1.4.1 Severity EntrySeverity 2013‑12‑20
1.3.6.1.4.1.19376.1.5.3.1.4.3 epSOS Patient Medication Instructions epsosPatientMedicationInstructions 2013‑12‑20
1.3.6.1.4.1.19376.1.5.3.1.4.3.1 Entry Medication FulFillment Instructions EntryMedicationFulFillmentInstructions 2013‑12‑20
1.3.6.1.4.1.19376.1.9.1.1.1.1 Dosage Instruction Content DosageInstructionContent 2016‑01‑08 13:04:49
1.3.6.1.4.1.19376.1.9.1.3.1 Medicine Entry Content Module MedicineEntryContentModule 2016‑01‑08 13:04:49
1.3.6.1.4.1.19376.1.9.1.3.2 Prescription Item Entry Content Module PrescriptionItemEntry 2016‑01‑08 13:04:49
1.3.6.1.4.1.19376.1.9.1.3.3 Pharmaceutical Advice Item Entry Content Module PharmaceuticalAdviceItemEntryContentModule 2016‑01‑08 11:13:04
1.3.6.1.4.1.19376.1.9.1.3.5 Pharmaceutical Advice Concern Entry Content Module PharmaceuticalAdviceConcernEntryContentModule 2016‑01‑08 11:13:04
2.16.756.5.30.1.1.1.1.3.10.1 eCurrentMedication V1 CDA-CH-EMED-eCurrentMedication-V1 2016‑05‑13 22:09:17
2.16.756.5.30.1.1.1.1.3.10.2 eRezept V1 CDA-CH-EMED-eRezept-V1 2016‑05‑21 10:48:21
2.16.756.5.30.1.1.1.1.3.10.2.10.1.10.3.1 eCurrentMedication Section Content Module CH-EMED-MedicationTreatmentPlanSectionContentModule 2016‑05‑21 23:12:35
2.16.756.5.30.1.1.1.1.3.10.2.10.1.10.4.1 Medication Treatment Plan Item Entry Content Module CH-EMED-MedicationTreatmentPlanEntryContentModule 2016‑06‑13 14:23:13
2.16.756.5.30.1.1.1.1.3.10.2.10.2.10.3.1 Prescription Section Content Module CH-EMED-PrescriptionSectionContentModule 2016‑06‑06 15:45:17
2.16.756.5.30.1.1.1.1.3.10.2.10.2.10.4.1 Prescription Item Entry Content Module CH-EMED-PrescriptionItemEntryContentModule 2016‑06‑25 12:22:37
2.16.756.5.30.1.1.1.1.3.10.2.10.3.10.3.1 Dispense Section Content Module CH-EMED-DispenseSectionContentModule 2016‑06‑06 15:58:22
2.16.756.5.30.1.1.1.1.3.10.2.10.3.10.4.1 Dispense Item Entry Content Module CH-EMED-DispenseItemEntryContentModule 2016‑06‑17 23:36:35
2.16.756.5.30.1.1.1.1.3.10.2.10.4.10.3.1 Pharmaceutical Advice Section Content Module CH-EMED-PharmaceuticalAdviceSectionContentModule 2016‑06‑06 16:43:15
2.16.756.5.30.1.1.1.1.3.10.2.10.4.10.4.1 Pharmaceutical Advice Item Entry Content Module CH-EMED-PharmaceuticalAdviceItemEntryContentModule 2016‑06‑25 13:03:02
2.16.756.5.30.1.1.1.1.3.10.2.10.4.10.4.2 Pharmaceutical Advice Concern Item Entry Content Module CH-EMED-PharmaceuticalAdviceConcernItemEntryContentModule 2016‑07‑12 16:30:50
2.16.756.5.30.1.1.1.1.3.10.2.10.10.4.1 Dosage Instructions Entry Content Module CH-EMED-DosageInstructionsEntryContentModule 2016‑06‑13 14:54:37
2.16.756.5.30.1.1.1.1.3.10.2.10.10.4.2 Manufactured Material Entry Content Module CH-EMED-ManufacturedMaterialEntryContentModule 2016‑06‑13 11:02:48
2.16.756.5.30.1.1.1.1.3.10.2.10.10.4.3 Prescribed Quantity Entry Content Module CH-EMED-PrescribedQuantityEntryContentModule 2016‑06‑13 15:35:46
2.16.756.5.30.1.1.1.1.3.10.2.10.10.4.4 Treatment Reason Entry Content Module CH-EMED-TreatmentReasonEntryContentModule 2016‑06‑13 17:25:54
2.16.756.5.30.1.1.1.1.3.10.2.10.10.4.5 Treatment State Entry Content Module CH-EMED-TreatmentStateEntryContentModule 2016‑06‑13 16:44:53
2.16.756.5.30.1.1.1.1.3.10.2.10.10.4.6 MTP Reference Entry Content Module CH-EMED-MTPReferenceEntryContentModule 2016‑07‑07 17:23:02
2.16.756.5.30.1.1.1.1.3.10.2.10.10.4.7 Extemporaneous Formulation Entry Content Module CH-EMED-ExtemporaneousFormulationEntryContentModule 2016‑07‑13 09:35:34
2.16.756.5.30.1.1.1.1.3.10.2.10.10.4.8 Prescription Type Entry Content Module CH-EMED-PrescriptionTypeEntryContentModule 2016‑07‑13 10:29:27
2.16.756.5.30.1.1.1.1.3.10.2.10.10.4.9 Medication Type Entry Content Module CH-EMED-MedicationTypeEntryContentModule 2016‑07‑07 17:23:02
2.16.756.5.30.1.1.1.1.3.10.3 eAbgabeAnwendungsDokument V1 CDA-CH-EMED-AbgabeAnwendungsDokument-V1 2016‑05‑21 10:49:53
2.16.756.5.30.1.1.1.1.3.10.4 eMedicationComment V1 CDA-CH-EMED-eMedicationComment-V1 2016‑05‑21 10:50:30
2.16.756.5.30.1.1.1.1.3.10.10.2.1 <CH-EMED-AUTO> CH-EMED-AUTO 2016‑06‑09 10:31:27
2.16.756.5.30.1.1.1.1.3.10.10.2.2 <CH-EMED-NAME> CH-EMED-NAME 2016‑06‑09 13:13:26
2.16.756.5.30.1.1.1.1.3.10.10.2.3 <CH-EMED-RORG> CH-EMED-RORG 2016‑06‑09 13:28:20
2.16.756.5.30.1.1.1.1.3.10.10.2.4 <CH-EMED-CONT> CH-EMED-CONT 2016‑06‑09 14:13:53
2.16.756.5.30.1.1.1.1.3.10.10.2.5 <CH-EMED-PAT> CH-EMED-PAT 2016‑06‑08 16:23:54
2.16.756.5.30.1.1.10.2.5 CDA legalAuthenticator CDAlegalAuthenticator 2009‑01‑27
2.16.756.5.30.1.1.10.2.13 <CDA-CH-REPL> CDA_CH_REPL 2016‑05‑18
2.16.756.5.30.1.1.10.2.18 <CDA-CH-TPLT> CDA-CH-TPLT 2016‑06‑06
2.16.756.5.30.1.1.10.2.19 <CDA-CH-CONF> CDA_CH_CONF 2016‑06‑06
2.16.756.5.30.1.1.10.2.20 <CDA-CH-SETV> CDA_CH_SETV 2015‑12‑18
2.16.756.5.30.1.1.10.2.22 <CDA-CH-DOCL> CDA_CH_DOCL 2015‑12‑18
2.16.756.5.30.1.1.10.2.24 CDA TypeId CDAtypeId 2015‑12‑18
2.16.756.5.30.1.1.10.2.25 <CDA-CH-RELM> CDA_CH_RELM 2015‑12‑18
2.16.756.5.30.1.1.10.2.26 CDA-CH Non-Human Subject (recordTarget) cdach_header_RecordTargetNonHumanSubject 2016‑07‑14
2.16.756.5.30.1.1.10.2.26 <CDA-CH-TPLT-V12> CDA-CH-TPLT-V12 2015‑12‑18
2.16.756.5.30.1.1.10.2.26 <CDA-CH-TPLT> CDA-CH-TPLT-V12 2016‑07‑13
2.16.756.5.30.1.1.10.3.2 CDA-CH Remarks Section CDA-CH-RemarksSection 2016‑03‑17
2.16.756.5.30.1.1.10.3.4 CDA-CH Coded Vital Signs Section CDA-CH-CodedVitalSignsSection 2016‑07‑02
2.16.756.5.30.1.1.10.3.6 CDA-CH Allergies and other Adverse Reactions Section CDA-CH-AllergiesOtherAdverseReactionsSection 2016‑07‑02
2.16.756.5.30.1.1.10.4.2 CDA-CH Remarks Entry CDACH-RemarksEntry 2016‑03‑17
2.16.756.5.30.1.1.10.4.20 CDA-CH Vital Signs Organizer Entry CDA-CH-VitalSignsOrganizerEntry 2016‑07‑02
2.16.756.5.30.1.1.10.4.21 CDA-CH Vital Signs Observation CDA-CH-VitalSignsObservation 2016‑07‑02
2.16.756.5.30.1.1.10.9.1 CDA RealmCode CDArealmCode 2015‑12‑18
2.16.756.5.30.1.1.10.9.3 CDA Document Id CDAid 2015‑12‑18
2.16.756.5.30.1.1.10.9.5 CDA Document Language Code CDAlanguageCode 2015‑12‑18
2.16.756.5.30.1.1.10.9.7 CDA SetId VersionNumber CDAsetIdversionNumber 2015‑12‑18
2.16.756.5.30.1.1.10.9.10 CDA Person CDAPerson 2015‑12‑18
2.16.756.5.30.1.1.10.9.11 CDA Organization CDAOrganization 2015‑12‑18
2.16.756.5.30.1.1.10.9.12 CDA AssignedEntity CDAAssignedEntity 2015‑12‑18
2.16.756.5.30.1.127.77.4.10.6 CDA relatedDocument CDArelatedDocument 2016‑06‑06 10:57:39

Liste von Value Set Identifiern in diesem Projekt

Id Anzeigename Name Eingangsdatum
1.3.6.1.4.1.12559.11.10.1.3.1.42.1 epSOSHealthcareProfessionalRoles epSOSHealthcareProfessionalRoles 2013‑06‑03
1.3.6.1.4.1.12559.11.10.1.3.1.42.13 epSOSSeverity epSOSSeverity 2013‑06‑03
2.16.756.5.30.1.1.11.1 Swiss Confidentiality Codes SwissConfidentialityCodes 2016‑05‑27
2.16.756.5.30.1.1.11.3 Swiss Role Author EPD SwisRoleAuthor 2016‑06‑09
2.16.756.5.30.1.1.11.4 Swiss Author Speciality EPD SwissAuthorSpeciality 2016‑06‑09
2.16.756.5.30.1.1.11.5 Vital Signs Observation VitalSignsObservation 2016‑07‑02
2.16.756.5.30.1.127.77.4.11.1 PrescriptionType CH-EMED-PrescriptionType 2016‑06‑25 10:57:01
2.16.756.5.30.1.127.77.4.11.2 TimingEvent CH-EMED-TimingEvent 2016‑06‑30 14:58:13
2.16.756.5.30.1.127.77.4.11.3 eMedicationCommentType CH-EMED-eMedicationCommentTyp 2016‑07‑12 21:26:21
2.16.756.5.30.1.127.77.4.11.4 ProblemType PCCTFVol2ProblemType 2016‑07‑12 21:49:34
2.16.756.5.30.1.127.77.4.11.5 eRezeptType CH-EMED-eRezeptType 2016‑07‑12 23:28:18
2.16.756.5.30.1.127.77.4.11.6 MedicationType CH-EMED-MedicationType 2016‑07‑13 13:25:53
2.16.840.1.113883.1.11.1 AdministrativeGender AdministrativeGender 2011‑07‑26
2.16.840.1.113883.1.11.1 AdministrativeGender AdministrativeGender 2014‑03‑26
2.16.840.1.113883.1.11.10282 ParticipationSignature ParticipationSignature 2014‑03‑26
2.16.840.1.113883.1.11.11526 HumanLanguage HumanLanguage 2011‑07‑26
2.16.840.1.113883.1.11.11526 HumanLanguage HumanLanguage 2014‑03‑26
2.16.840.1.113883.1.11.14411 OrderableDrugForm OrderableDrugForm 2011‑07‑26
2.16.840.1.113883.1.11.14411 OrderableDrugForm OrderableDrugForm 2014‑03‑26
2.16.840.1.113883.1.11.14581 RouteOfAdministration RouteOfAdministration 2011‑07‑26
2.16.840.1.113883.1.11.14581 RouteOfAdministration RouteOfAdministration 2014‑03‑26
2.16.840.1.113883.1.11.16643 SeverityObservation SeverityObservation 2011‑07‑26
2.16.840.1.113883.1.11.16643 SeverityObservation SeverityObservation 2014‑03‑26

Datensätze, Codes, OIDs und Regeln: diese Information wird zu Anzeigezwecken genutzt.